Koorevaar C T, Hu H P, Lemmens A, van Kampen A
Department of Orthopaedics, University Hospital of Nijmegen, The Netherlands.
Arch Orthop Trauma Surg. 1999;119(3-4):183-5. doi: 10.1007/s004020050386.
Ninety-five patients underwent primary total hip arthroplasty and routinely received ibuprofen for 5 days as prophylaxis for heterotopic ossification. This group was compared with a group of 99 patients who received indomethacin for 7 days as prophylaxis. After a follow-up of 1 year, the incidence of heterotopic ossification in the ibuprofen group was significantly higher than in the indomethacin group. The widespread ossification, Brooker grades III and IV, was prevented better by indomethacin than by ibuprofen. We conclude that ibuprofen for 5 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.
95例患者接受了初次全髋关节置换术,并常规服用布洛芬5天以预防异位骨化。该组与99例接受吲哚美辛7天预防治疗的患者进行比较。随访1年后,布洛芬组异位骨化的发生率显著高于吲哚美辛组。吲哚美辛比布洛芬能更好地预防广泛骨化(布鲁克分级III级和IV级)。我们得出结论,术后服用5天布洛芬对初次全髋关节置换术后异位骨化的预防无效。